DE SIMONE, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 30.303
AS - Asia 16.050
EU - Europa 8.519
SA - Sud America 3.774
AF - Africa 628
Continente sconosciuto - Info sul continente non disponibili 559
OC - Oceania 24
Totale 59.857
Nazione #
US - Stati Uniti d'America 29.112
SG - Singapore 5.097
CN - Cina 3.793
HK - Hong Kong 3.444
BR - Brasile 3.025
IT - Italia 2.643
VN - Vietnam 1.703
BG - Bulgaria 1.318
SE - Svezia 904
CA - Canada 891
DE - Germania 715
RU - Federazione Russa 595
FR - Francia 587
TR - Turchia 469
GB - Regno Unito 465
JP - Giappone 338
AR - Argentina 296
FI - Finlandia 284
IN - India 250
AT - Austria 233
CI - Costa d'Avorio 171
BD - Bangladesh 169
UA - Ucraina 145
SN - Senegal 116
EC - Ecuador 114
PL - Polonia 107
ID - Indonesia 105
ES - Italia 101
IQ - Iraq 101
MX - Messico 101
ZA - Sudafrica 93
CO - Colombia 85
KR - Corea 78
CH - Svizzera 77
NL - Olanda 72
PK - Pakistan 69
PY - Paraguay 61
MA - Marocco 60
SA - Arabia Saudita 60
UZ - Uzbekistan 56
EG - Egitto 53
UY - Uruguay 48
VE - Venezuela 48
EE - Estonia 47
JM - Giamaica 47
CL - Cile 43
PH - Filippine 43
BE - Belgio 36
PE - Perù 34
CR - Costa Rica 30
TN - Tunisia 30
CZ - Repubblica Ceca 28
KE - Kenya 26
NP - Nepal 26
MY - Malesia 23
JO - Giordania 21
RO - Romania 21
IR - Iran 20
HN - Honduras 19
AU - Australia 18
BO - Bolivia 18
IE - Irlanda 18
KZ - Kazakistan 18
AE - Emirati Arabi Uniti 17
LT - Lituania 17
PS - Palestinian Territory 17
DZ - Algeria 16
AZ - Azerbaigian 15
DO - Repubblica Dominicana 15
GT - Guatemala 15
NG - Nigeria 14
OM - Oman 14
PT - Portogallo 14
RS - Serbia 14
ET - Etiopia 12
MD - Moldavia 12
TT - Trinidad e Tobago 12
TW - Taiwan 12
AL - Albania 11
PA - Panama 10
EU - Europa 9
GE - Georgia 9
IL - Israele 9
KG - Kirghizistan 9
NI - Nicaragua 9
BB - Barbados 8
BJ - Benin 8
BZ - Belize 8
GR - Grecia 8
LB - Libano 8
PR - Porto Rico 8
TH - Thailandia 8
BH - Bahrain 7
BY - Bielorussia 7
HU - Ungheria 7
LK - Sri Lanka 7
LY - Libia 6
SK - Slovacchia (Repubblica Slovacca) 6
BA - Bosnia-Erzegovina 5
HR - Croazia 5
Totale 59.206
Città #
Hong Kong 3.416
Ashburn 3.129
Woodbridge 2.934
Singapore 2.820
Houston 2.059
Fairfield 2.021
Dallas 1.721
San Jose 1.573
Sofia 1.314
Chandler 1.063
Shanghai 1.062
Ann Arbor 1.032
Santa Clara 891
Beijing 885
Serra 881
Seattle 847
New York 793
Princeton 733
Wilmington 711
Ottawa 698
Cambridge 689
Council Bluffs 610
Boardman 567
Los Angeles 494
Lawrence 490
Milan 480
Medford 460
Ho Chi Minh City 453
Lauterbourg 421
Des Moines 408
Istanbul 325
Tokyo 325
Hanoi 282
Buffalo 270
Redondo Beach 260
São Paulo 225
Nanjing 222
Florence 201
Vienna 187
Munich 177
Abidjan 169
Helsinki 145
Dong Ket 140
Jacksonville 134
London 133
Dearborn 127
Pisa 124
San Diego 119
Dakar 115
Ogden 108
Frankfurt am Main 101
Hefei 97
Warsaw 91
Rio de Janeiro 90
Nanchang 88
Shenyang 81
Rome 78
Boulder 77
Orem 75
Chicago 69
Changsha 68
Izmir 65
Haiphong 62
Hebei 61
Belo Horizonte 60
Montreal 59
Redwood City 59
Seoul 59
Brasília 58
Nuremberg 53
Turku 52
Columbus 51
Tashkent 49
Phoenix 48
Chennai 47
Stockholm 46
Paris 45
Porto Alegre 45
Da Nang 44
Brooklyn 43
Curitiba 43
Grafing 43
Kunming 43
Montevideo 43
Norwalk 43
San Francisco 43
Toronto 43
Fuzhou 42
Guangzhou 42
Johannesburg 42
Tallinn 42
Bern 41
Guayaquil 39
The Dalles 39
Falls Church 38
Baghdad 36
Casablanca 36
Tianjin 36
Dhaka 35
Jiaxing 35
Totale 42.168
Nome #
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up 281
Modification of immunosuppressive therapy as risk factor for complications after liver transplantation. 254
Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. 249
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes 246
Use of Elderly Donors in Liver Transplantation: A Paired-match Analysis at a Single Center 241
Open-source as an enabling approach for the introduction of artificial intelligence in healthcare 240
The Tuscany model of a regional transplantation service authority: Organizzazione Toscana Trapianti 230
Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates 221
Circulating gamma-glutamyltransferase fractions in cirrhosis 214
Perfusion machines and hepatocellular carcinoma: A good match between a marginal organ and an advanced disease? 214
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis 212
Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes 212
Functional and survival analysis of isolated human islets 210
Severe liver trauma: the transplant surgeon's perspective. A case report 209
Safety and feasibility of electrochemotherapy in patients with unresectable colorectal liver metastases: A pilot study. 206
Multi-locular thymic cysts after acute pancreatitis in a liver transplant recipient 204
Increased FNDC5/Irisin expression in human hepatocellular carcinoma. 203
Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature 202
Multi-layer nanoencapsulation of human pancreatic islets 197
Anti-inflammatory Signaling During Ex Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation 197
Dual aortic and portal perfusion at procurement prevents ischaemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study. 197
Adie tonic pupil associated to endometriosis 196
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study 196
FAILURE OF ENDOSCOPY FOR NONANASTOMOTIC BILIARY STRICTURES AFTER LIVER TRANSPLANTATION 194
Ex vivo efficacy demonstration of a laser fenestration system for endovascular abdominal aortic aneurysm repair (EVAR) 194
Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease? 193
Aortic valve-sparing procedure—a durable choice in liver transplantation recipient 193
Nurses' knowledge and application of evidence-based guidelines for preventing ventilator-associated pneumonia 191
The impact of everolimus on renal function in maintenance liver transplantation 191
ENDOSCOPIC MANAGEMENT OF POST-LIVER TRANSPLANT BILIARY COMPLICATIONS: OUTCOME ANALYSIS OF 751 PROCEDURES 191
Posttransplant hepatocellular carcinoma metastasis at a skull trauma site 190
Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery 189
Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation. 189
MULTIPLE CRANIAL NERVE PALSIES IN TESTICULAR LYMPHOMA: REPORT OF A CASE 188
Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. 187
COMMON POLYMORPHISM IN THE MCP-1 GENE REGULATORY REGION INFLUENCES MCP-1 EXPRESSION AND FUNCTION OF ISOLATED TYPE 2 PANCREATIC ISLETS 184
The epidemiology of brain death in Tuscany: is there need for novel indicators? 182
Interregional allocation models for liver transplantation 182
The quality assurance program of organ donation in Tuscany 181
Esofagomiotomia laparoscopica nel trattamento dell’acalasia esofagea. 181
Salvage of an octogenarian liver graft using normothermic perfusion. A case report 181
Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study. 180
2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation 179
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 179
Transplant nursing: scope and standards of practice 178
Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation 177
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 177
AVOIDING CALCINEURIN INHIBITORS IN THE EARLY POST-OPERATIVE COURSE IN HIGH-RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 176
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: Preliminary results of the protect trial 176
In situ diode laser fenestration: An ex-vivo evaluation of irradiation effects on human aortic tissue 176
An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation 175
The "You Are Not Alone" care program for liver transplantation 170
Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study. 170
Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation 169
A selective policy of tumor down staging helps improve the results of liver transplantation for HCC patients within the Milan criteria 168
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets 168
Post-transplant liver graft schistosomiasis in a migrant from sub-saharan africa. 167
Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution 165
AVOIDING CALINEURIN INHIBITORS IN THE EARLY POST OPERATIVE COURSE IN HIGH RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 163
Involvement of the receptor for advanced glycation end products in liver transplantation 161
Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair 161
Aminopyrine breath test in cirrhotic patients awaiting liver transplantation: do we really need it ? 160
A non-meld based allocation algorithm for HCC patients undergoing liver transplantation allows favorable results: The Tuscany experience 160
Nonagenarian Grafts for Liver Transplantation 160
Strategies to optimize the use of marginal donors in liver transplantation. 157
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 157
Atypical acute leukemia early after liver transplantation 156
What is the role of the receptor for advanced glycation endproducts-ligand axis in liver injury? 156
COVID-19 infection requires strengthening of the chronic care model: the impact on liver transplant practice at a high-volume center in Italy 156
Refusal to donate after brain death 155
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 155
Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors 154
Locoregional treatments for bridging and downstaging hcc to liver transplantation 154
Combined or staged liver transplantation and duodeno-pancreasectomy: Indications,complications and expansion of wait list criteria 153
Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey 152
Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation 151
Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients 151
EVEROLIMUS-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A REDUCED RISK OF NEW- ONSET MALIGNANCIES AFTER LIVER TRANSPLANTATION 151
Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants. 151
THE PARADOX OF ORGAN SHORTAGE AND EQUITY: HOW TO SOLVE THE RIDDLE ? 150
Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting. 150
Patient satisfaction among liver transplant recipients: single-center survey. 150
Efficiency of the Tissue Procurement Process: What Evaluation Tools? 150
The international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: Findings from the cross-sectional BRIGHT study. 150
1315-P: Pre– and Post–Liver Transplant Diabetes (DM) and Prediabetes (PD), and the Impact on Transplant Outcomes—Results of a Large Single-Center Study 149
Lower level of care adversely impacts the outcome of liver transplantation 149
7-T MRI of explanted liver and ex-vivo pancreatic specimens: prospective study protocol of radiological-pathological correlation feasibility (the EXLIPSE project) 148
Successful Transplant of a Nonagenarian Liver Graft With Fully Replaced Right Hepatic Artery Reconstruction. 147
A model for southern mediterranean research institute self-assessment: A SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt 146
null 146
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma 146
A common polymorphism in the MCP-1 gene regulatory regioninfluences MCP-1 expression and function of isolated Type 2 pancreatic islets 145
Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study 145
The organizational model of the interregional transplant agency Organizzazione Centro-Sud Trapianti. 145
Donor diabetes and prolonged cold ischemia time increase the risk of graft failure after liver transplant: Should we need a redefinition of the donor risk index? 143
Use of liver grafts ≥ 80 years. The lessons learned after over 150 transplants 143
Immunoadsorption with protein A in humoral rejection of kidney transplants. 142
A model for Southern Mediterranean research institute self-assessment: a SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt). 142
What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? 140
Liver transplantation in type III von Willebrand disease 140
Totale 17.702
Categoria #
all - tutte 182.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.366 0 0 65 207 940 691 99 236 244 110 170 1.604
2022/20233.794 648 451 219 276 393 511 40 266 650 21 279 40
2023/20243.162 229 335 273 204 500 583 126 91 134 57 133 497
2024/202512.775 86 584 103 790 760 1.109 1.170 931 1.458 1.972 1.440 2.372
2025/202616.229 642 1.926 2.524 2.492 1.424 1.487 1.970 652 987 1.247 547 331
2026/20273.399 351 1.194 1.854 0 0 0 0 0 0 0 0 0
Totale 59.857